No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
EXPO Exponent
- 97.400
- +2.360+2.48%
Close Jul 11 16:00 ET
- 97.400
- 0.0000.00%
Post 16:20 ET
4.94BMarket Cap49.44P/E (TTM)
98.100High95.860Low190.52KVolume96.860Open95.040Pre Close18.55MTurnover0.38%Turnover Ratio50.21P/E (Static)50.67MShares102.41752wk High13.19P/B4.86BFloat Cap63.99652wk Low1.06Dividend TTM49.92MShs Float123.889Historical High1.09%Div YieldTTM2.36%Amplitude0.426Historical Low97.369Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Exponent's (NASDAQ:EXPO) Investors Will Be Pleased With Their Decent 68% Return Over the Last Five Years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd like to see the share price move up more than the market average. Unfortunatel
Exponent to Announce Second Quarter of Fiscal Year 2024 Results and Host Quarterly Conference Call on July 25, 2024
Exponent (EXPO) Shares Sold Off as It Fell Short of Estimates
Exponent(EXPO.US) Director Sells US$667.36K in Common Stock
$Exponent(EXPO.US)$ Director JOHNSTON PAUL R sold 7,000 shares of common stock on Jun 20, 2024 at an average price of $95.3369 for a total value of $667.36K.Source: Announcement What is statement of c
Exponent(EXPO.US) Director Sells US$668.52K in Common Stock
$Exponent(EXPO.US)$ Director JOHNSTON PAUL R sold 7,000 shares of common stock on Jun 17, 2024 at an average price of $95.5034 for a total value of $668.52K.Source: Announcement What is statement of c
Europastry Controlling Shareholder Exponent Plans to Sell Shares in IPO
Europastry Controlling Shareholder Exponent Plans to Sell Shares in IPO
Comments
Analysts show less optimism post recent results, cutting revenue forecasts and significantly lowering earnings per share estimates. The projected 1.8% annual growth rate till 2024 is far below the historical 7.0% p.a. growth over the past five years.
Exponent, Inc. (NASDAQ:EXPO) Just Reported And Analysts Have Been Cutting Their Estimates 1
The increase in dividend and stock repurchase authorization reflects the company's confidence in its long-term business trajectory and its commitment to delivering long-term value for shareholders.
Despite a recent share price drop, Exponent, Inc. may still hold potential for long-term investors with its consistent 13% annual return over five years. The market appears pessimistic despite the company's impressive EPS growth.
Despite Exponent's strong past earnings, its P/E is viewed as overvalued due to weaker future growth forecasts. The current elevated P/E and the predicted earnings slowdown could soon impact the stock price.
Exponent's impressive returns on its growing capital and its stable, high ROCE hint at strong future performance. Despite pricier stocks, the company's sound fundamentals warrant further research.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg